Earnings Per Share, Basic in USD/shares of Vistagen Therapeutics, Inc. from Q2 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2012 to Q3 2025.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.54 USD/shares, a 28.6% decline year-over-year.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 177% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -1.67 USD/shares, a 9.87% decline from 2023.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.52 USD/shares, a 82.1% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -8.51 USD/shares, a 15.3% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Vistagen Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 -$1 $0 -28.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$1 $0 $0 -34.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$1 $0 -$1 -247% Jan 1, 2025 Mar 31, 2025 10-K 2025-06-17
Q4 2024 $0 $0 $0 -109% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $0 $0 +$0.24 +36.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 $0 $0 +$0.59 +62.8% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$1 $0.30 +$2.01 Jan 1, 2024 Mar 31, 2024 10-K 2025-06-17
Q4 2023 -$3 $0 +$1.20 +84.5% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-13
Q3 2023 -$4 -$1 +$1.88 +74% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$6 -$1 +$1.93 +67.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$8 -$2 +$0.71 +29.3% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-28
Q4 2022 -$9 -$1 +$0.17 +10.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$9 -$3 -$1 -24.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$8 -$3 -$2 -124% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$7 -$2 Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 -$2 Oct 1, 2021 Dec 31, 2021 10-K 2023-06-28
Q3 2021 -$2 Jul 1, 2021 Sep 30, 2021 10-K 2023-06-28
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-K 2023-06-28
Q4 2015 -$2 -$1 -132% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-16
Q3 2015 -$5 -$4 -233% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q1 2015 -$10 -$4 -$3 -170% Jan 1, 2015 Mar 31, 2015 10-K 2016-06-24
Q4 2014 -$7 -$1 -$1 -800% Oct 1, 2014 Dec 31, 2014 10-K 2016-06-24
Q3 2014 -$6 -$2 $0 -17% Jul 1, 2014 Sep 30, 2014 10-K 2016-06-24
Q2 2014 -$6 -$4 -$4 -2156% Apr 1, 2014 Jun 30, 2014 10-K 2016-06-24
Q1 2014 -$2 -$2 Jan 1, 2014 Mar 31, 2014 10-K 2015-06-29
Q4 2013 $0.12 +$0.97 Oct 1, 2013 Dec 31, 2013 10-K 2015-06-29
Q3 2013 -$1 Jul 1, 2013 Sep 30, 2013 10-K 2015-06-29
Q2 2013 $0.18 +$0.29 Apr 1, 2013 Jun 30, 2013 10-K 2015-06-29
Q4 2012 -$1 Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14

Vistagen Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 $0 -9.87% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 -$2 +$6.99 +82.1% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 -$9 -$1 -15.3% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 -$7 -$7 -1406% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $0 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2015 -$29 -$19 -176% Apr 1, 2015 Mar 31, 2016 10-K 2016-06-24
2014 -$11 -$8 -290% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 -$3 -$3 -27100% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 $0.01 Apr 1, 2012 Mar 31, 2013 10-Q 2014-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.